Augustovski, F., Beratarrechea, A., Irazola, V., Rubinstein, F., Tesolin, P., Gonzalez, J. M., … Soriano, E. (2010). BL2 PATIENT PREFERENCES FOR BIOLOGIC AGENTS IN RHEUMATOID ARTHRITIS: A DISCRETE CHOICE EXPERIMENT. Value in Health, 13(7), A243–A243. https://doi.org/10.1016/s1098-3015(11)71863-0

Augustovski, F., A. Beratarrechea, V. Irazola, F. Rubinstein, P. Tesolin, J. M. Gonzalez, V. Lencina, et al. “BL2 PATIENT PREFERENCES FOR BIOLOGIC AGENTS IN RHEUMATOID ARTHRITIS: A DISCRETE CHOICE EXPERIMENT.” Value in Health 13, no. 7 (November 2010): A243–A243. https://doi.org/10.1016/s1098-3015(11)71863-0.

Augustovski F, Beratarrechea A, Irazola V, Rubinstein F, Tesolin P, Gonzalez JM, et al. BL2 PATIENT PREFERENCES FOR BIOLOGIC AGENTS IN RHEUMATOID ARTHRITIS: A DISCRETE CHOICE EXPERIMENT. Value in Health. 2010 Nov;13(7):A243–A243.

Augustovski, F., et al. “BL2 PATIENT PREFERENCES FOR BIOLOGIC AGENTS IN RHEUMATOID ARTHRITIS: A DISCRETE CHOICE EXPERIMENT.” Value in Health, vol. 13, no. 7, Elsevier BV, Nov. 2010, pp. A243–A243. Crossref, doi:10.1016/s1098-3015(11)71863-0.

Augustovski F, Beratarrechea A, Irazola V, Rubinstein F, Tesolin P, Gonzalez JM, Lencina V, Scolnik M, Wainmann C, Navarta D, Citera G, Soriano E. BL2 PATIENT PREFERENCES FOR BIOLOGIC AGENTS IN RHEUMATOID ARTHRITIS: A DISCRETE CHOICE EXPERIMENT. Value in Health. Elsevier BV; 2010 Nov;13(7):A243–A243.